复发高级别胶质瘤再程放疗:当前证据与实践考量
本文针对复发高级别胶质瘤和胶质母细胞瘤的再程放疗,指出其作为挽救治疗的重要性受限于前瞻性证据不足、治疗方式异质性和累积脑毒性担忧。现有研究提示经谨慎选择的患者可获得局部控制、症状缓解和神经功能保留,但未证实一致的总体生存获益。作者提出以危及器官为导向的实践框架,涵盖患者选择、靶区勾画、分次方案、累积剂量评估和系统治疗整合。
要点
- 再程放疗可用于经选择的复发高级别胶质瘤患者,但需个体化评估。
- 现有证据未证实一致的总体生存获益,局部控制和症状缓解可能实现。
- 治疗决策应综合体能状态、神经功能、病变体积、距前次放疗间隔及危及器官重叠。
核心结论
- 再程放疗可在经选择的复发高级别胶质瘤患者中安全实施,但治疗强度应与解剖、预后、替代方案和患者目标密切匹配。
研究设计与样本
- 本文为专家意见,总结支持脑部再程放疗的当代证据并讨论可用技术,同时提出以危及器官为导向的实践框架。
主要发现
- 现有研究提示经谨慎选择的患者可能获得有意义的局部控制、症状缓解和神经功能保留,但未证实一致的总体生存获益。
- 再程放疗的应用受限于前瞻性证据有限、治疗方式异质性和对脑及关键神经结构累积毒性的担忧。
关键数值与推荐
- 治疗决策需个体化评估体能状态、神经功能、病变体积和模式、距前次放疗间隔、预期预后、替代挽救方案及与前次照射危及器官的重叠。
- 实践框架涵盖患者选择、靶区勾画、分次方案、累积剂量评估和系统治疗整合。
临床怎么用
- 对复发高级别胶质瘤患者,再程放疗应基于危及器官驱动的框架进行个体化决策,治疗强度与解剖、预后、替代方案和患者目标保持一致。
局限性
- 前瞻性证据有限,治疗方式异质,且存在对脑和关键神经结构累积毒性的担忧。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Re-irradiation is an increasingly important salvage option for patients with recurrent high-grade glioma and glioblastoma, but its use is complicated by limited prospective evidence, heterogeneous treatment approaches, and concern for cumulative toxicity to the brain and critical neurologic structures. Available studies suggest that carefully selected patients may achieve meaningful local control, symptom relief, and preservation of neurologic function, although a consistent overall survival benefit has not been demonstrated. Treatment decisions therefore require individualized assessment of performance status, neurologic function, disease volume and pattern, interval from prior radiation therapy, expected prognosis, alternative salvage options, and overlap with previously irradiated organs at risk. In this expert opinion, we summarize the contemporary evidence supporting brain re-irradiation and discuss available techniques; we also describe a practical, organ-at-risk-driven framework for patient selection, target delineation, fractionation, cumulative dose assessment, and integration of systemic therapy. Re-irradiation can be delivered safely in selected patients, but treatment intensity should remain closely aligned with anatomy, prognosis, therapeutic alternatives, and patient goals.
引用
- Lee E, Tanguturi S. Re-irradiation for recurrent high-grade glioma: current evidence and practical considerations. Pract Radiat Oncol. 2026. PMID: 42858821. doi:10.1016/j.prro.2026.10.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。